Equitable Trust Co. bought a new position in shares of Colgate-Palmolive (NYSE:CL – Free Report) during the fourth quarter, Holdings Channel.com reports. The fund bought 2,334 shares of the company’s stock, valued at approximately $212,000.
Other large investors also recently modified their holdings of the company. Union Bancaire Privee UBP SA bought a new position in shares of Colgate-Palmolive in the fourth quarter valued at $32,000. Hager Investment Management Services LLC bought a new stake in shares of Colgate-Palmolive during the fourth quarter worth about $36,000. Reston Wealth Management LLC bought a new position in Colgate-Palmolive in the 3rd quarter valued at about $42,000. Synergy Asset Management LLC acquired a new position in Colgate-Palmolive during the 4th quarter valued at about $49,000. Finally, Capital Performance Advisors LLP bought a new stake in Colgate-Palmolive during the 3rd quarter worth approximately $53,000. 80.41% of the stock is currently owned by institutional investors.
Colgate-Palmolive Price Performance
CL opened at $87.35 on Wednesday. The firm has a 50-day moving average price of $90.14 and a 200-day moving average price of $96.69. Colgate-Palmolive has a twelve month low of $82.68 and a twelve month high of $109.30. The company has a quick ratio of 0.26, a current ratio of 0.41 and a debt-to-equity ratio of 9.46. The company has a market capitalization of $71.37 billion, a price-to-earnings ratio of 24.82, a PEG ratio of 4.12 and a beta of 0.44.
Colgate-Palmolive Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.29%. Colgate-Palmolive’s dividend payout ratio (DPR) is 56.82%.
Analyst Ratings Changes
CL has been the topic of a number of recent research reports. UBS Group dropped their target price on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a report on Monday, February 3rd. Raymond James reaffirmed an “outperform” rating and set a $105.00 price objective (down from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. JPMorgan Chase & Co. lowered their target price on shares of Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a report on Monday, February 3rd. Piper Sandler cut their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a report on Monday, January 6th. Finally, Barclays decreased their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research note on Friday, January 17th. One research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $101.16.
Check Out Our Latest Analysis on CL
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
- Five stocks we like better than Colgate-Palmolive
- What is the Hang Seng index?
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- NYSE Stocks Give Investors a Variety of Quality Options
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
- The 3 Best Blue-Chip Stocks to Buy Now
- U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.